By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CombiMatrix today reported a 31 percent increase year over year in its second-quarter revenues on an uptick in its diagnostic testing service revenues.

For the three months ended June 30, the firm posted revenues of $1.2 million, compared to $916,000 a year ago. Total revenues were comprised completely of diagnostic testing revenues, which rose 51 percent from $796,000 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.